Bacnos 40 (Number 501) (Paramesh Banerji Life Sciences LLC)


Welcome to the PulseAid listing for the Bacnos 40 (Number 501) drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Paramesh Banerji Life Sciences LLC
NON-PROPRIETARY NAME: Mezereum, Graphites
SUBSTANCE NAME: GRAPHITE; DAPHNE MEZEREUM BARK
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-10-29
END MARKETING DATE: 0000-00-00


Bacnos 40 (Number 501) HUMAN OTC DRUG Details:

Item DescriptionBacnos 40 (Number 501) from Paramesh Banerji Life Sciences LLC
LABELER NAME: Paramesh Banerji Life Sciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 30; 200([hp_C]/1; [hp_C]/1)
START MARKETING DATE: 2014-10-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69152-0501_0eace184-f5a6-5d21-e054-00144ff8d46c
PRODUCT NDC: 69152-0501
APPLICATION NUMBER:

Other GRAPHITE; DAPHNE MEZEREUM BARK Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Paramesh Banerji Life Sciences LLCBacnos 40 (Number 501)